IBIS-II Bone Mineral Density Changes

Monday 1st October | Ivana Sestak, IBIS-II trial statistician, presented at the 2018 American Society for Bone and Mineral Research in Montreal, Canada.  These are the first results reporting bone mineral density changes after stopping anastroxole in a breast cancer prevention participants.